Glomerular Disease in the Elderly

Clinics in Geriatric Medicine

Volumn 25, Issue 3, 2009, Pages 413-422

  Glassock, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glomerulonephritis; Immunosuppressive therapy; Nephrotic syndrome; Primary glomerular disease; Secondary glomerular disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BORTEZOMIB; CORTICOSTEROID; CORTICOTROPIN; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INTERFERON; LENOLINAMIDE; LOOP DIURETIC AGENT; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PREDNISONE; RENIN INHIBITOR; RITUXIMAB; TACROLIMUS; THALIDOMIDE DERIVATIVE; UNCLASSIFIED DRUG;

AGED; ALLERGIC GLOMERULONEPHRITIS; AMYLOIDOSIS; BED REST; CHRONIC GLOMERULONEPHRITIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; ELDERLY CARE; FATIGUE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; GOODPASTURE SYNDROME; HEMATURIA; HUMAN; IMMUNOGLOBULIN DEPOSITION; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FAILURE; MEDICAL DECISION MAKING; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; MYALGIA; NEPHRITIS; NEPHROTIC SYNDROME; PLASMAPHERESIS; PROGNOSIS; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REMISSION; REVIEW; SKIN BRUISING; SLEEP DISORDER; SODIUM RESTRICTION; TREATMENT DURATION;

AGE FACTORS; AGED; BIOPSY; CHRONIC DISEASE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE; KIDNEY GLOMERULUS; MORBIDITY; PROGNOSIS; SURVIVAL RATE; UNITED STATES;

EID: 70249140291     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2009.06.006     Document Type: Review

References (19)

1. Faubert P.F., and Porush J.G. Primary glomerular disease. Renal disease in the elderly. 2nd edition (1998), Marcel Dekker, Inc, New York 129-173
2. Glassock R.J. Glomerular disease in the elderly population. In: Oreopoulos D.G., Hazzard W.R., and Luke R. (Eds). Nephrology and geriatrics integrated (2000), Kluwer Academic Publishers, Dodrecht 57-66
3. Becker GJ, Fairley KF. Urinalysis. In: Textbook of nephrology, Massry S, Glassock R, 4th edition. Philadelphia: Lippincott, Williams and Wilkins; p. 1765-83
4. Ponticelli C., and Glassock R.J. Treatment of primary glomerulonephritis. 2nd edition (2009), Oxford University Press, Oxford p. 1-476
5. Moutzouris D.-A., Herlitz L., Appel G.A., et al. Renal biopsy in the very elderly. Clin J Am Soc Nephrol 4 (2009) 1073-1082
6. Vendemia F. The diagnosis of renal disease in elderly patients. What role is there for renal biopsy?. In: Nunez J.F.M., Cameron J.S., and Oreopoulos D.G. (Eds). The aging kidney in health and disease (2008), Springer, New York 307-328
7. Passerini P., and Ponticelli C. Membranous nephropathy. In: Ponticelli C., and Glassock R. (Eds). Treatment of primary glomerular disease. 2nd edition (2009), Oxford University Press, Oxford 261-312
8. Glassock R.J. Prophylactic anti-coagulation in nephrotic syndrome: a clinical conundrum. J Am Soc Nephrol 18 (2007) 2221-2225
9. Segarra A., Praga M., Ramos N., et al. Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients. Clin J Am Soc Nephrol 4 (2009) 1083-1088
10. Moroni G., and Ponticelli C. Acute post-infectious glomerulonephritis. In: Ponticelli C., and Glassock R. (Eds). Treatment of primary glomerular disease. 2nd edition (2009), Oxford University Press, Oxford 153-178
11. Glassock R.J., and Lee G. Immunoglobulin A nephropathy. In: Ponticelli C., and Glassock R. (Eds). Treatment of primary glomerular disease. 2nd edition (2009), Oxford University Press, Oxford 313-374
12. Scolari F., and Ponticelli C. Focal and segmental glomerulosclerosis. In: Ponticelli C., and Glassock R. (Eds). Treatment of primary glomerular disease. 2nd edition (2009), Oxford University Press, Oxford 215-260
13. Nachman P., and Glassock R. Crescentic glomerulonephritis. In: Ponticelli C., and Glassock R. (Eds). Treatment of primary glomerular disease. 2nd edition (2009), Oxford University press, Oxford 399-434
14. Coppo R., and Ponticelli C. Minimal change nephropathy. In: Ponticelli C., and Glassock R. (Eds). Treatment of primary glomerular disease. 2nd edition (2009), Oxford University Press, Oxford 179-214
15. Faubert P.F., and Porush J.G. Renal involvement in systemic disease. Renal disease in the elderly. 2nd edition (1998), Marcel Dekker, Inc, New York 175-237
16. Bjoneklett R., Vikse B.E., Svarstad E., et al. Long-term risk of cancer in membranous nephropathy patients. Am J Kidney Dis 50 (2007) 396-403
17. Dember L.M. Amyloidosis-associated kidney disease. J Am Soc Nephrol 17 (2006) 3458-3471
18. Lin J., Markowitz G.A., Valeri A.M., et al. Renal immunoglobulin deposition disease: the clinical spectrum. J Am Soc Nephrol 12 (2001) 1482-1492
19. Nasr S.H., and D'Agati V.D. Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol 18 (2007) 2032-2036